InNexus Biotechnology Inc. CEO to Present at the 7th Annual Biotechnology Industry Organization (BIO) Investor Forum

BRITISH COLUMBIA, Canada, Oct. 28 /CNW/ -- InNexus Biotechnology Inc., (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS; http://www.ixsbio.com), a drug development company commercializing the next generation of monoclonal antibodies based on its Dynamic Cross Linking (DXL(TM)) technology, announces that Jeff Morhet, CEO and Chairman, will present at the 7th Annual BIO Investor Forum on October 30, 2008.
MORE ON THIS TOPIC